However, it’s important to keep expectations realistic 
. Most of this research is still in early or preclinical stages. That means:
Human trials are still limited or ongoing
Long-term safety is not yet fully established
Effectiveness in real-world patients remains to be confirmed
So while this is a promising development, it’s not yet an available treatment.
Still, the direction of this research marks a significant shift—from managing bone loss to potentially restoring bone itself.
